new moon glutathione fda Soft Glow Approval Introducing 𝐌𝐨𝐨𝐧 𝐃𝐫𝐨𝐩 𝐑𝐚𝐝𝐢𝐚𝐧𝐭 𝐆𝐥𝐨𝐰

MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial

Programs may start from a customer-supplied small molecule, an expected metabolite structure, or a labeled-handle concept, and can be aligned with broader amino acid conjugation, custom bioconjugation services, or thiol-reactive route planning informed by maleimide conjugation considerations when appropriate

Retatrutide is the newest weight loss medication that acts as a triple agonist at GLP-1, GIP, and glucagon receptors

Soothing & Anti-Aging Enriched with Centella Asiatica and Adenosine to calm irritated skin and boost elasticity for firm and smooth skin